The severity of ICU-acquired pneumonia

Current Infectious Disease Reports

Volumn 15, Issue 5, 2013, Pages 380-384

  Marechal, Hugues ^a   Layios, Nathalie ^a   Damas, Pierre ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Attributable mortality; Intensive care unit; Severity of illness; SOFA score; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; ENTEROBACTERIACEAE; HAEMOPHILUS INFLUENZAE; HEALTH CARE QUALITY; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MORTALITY; OBSERVATIONAL STUDY; ORGAN DYSFUNCTION SCORE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; RISK REDUCTION; SEPSIS; SEPTIC SHOCK; STREPTOCOCCUS PNEUMONIAE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84884587497     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-013-0359-8     Document Type: Review

References (33)

1. Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323-9.
2. Klompas M. The paradox of ventilator-associated pneumonia prevention measures. Crit Care. 2009;13:315.
3. •• Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903. An old paper with a still useful comprehensive review on all aspects of VAP except prevention.
4. Sadfar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33:2184-93.
5. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344-53.
6. Alberti C, Brun-Buisson C, Burchard H, et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28:108-21.
7. Alberti C, Brun-Buisson C, Goodman S, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Resp Crit Care Med. 2003;168:77-84.
8. Alberti C, Brun-Buisson C, Chevret S, et al. Systemic inflammatory response and progresion to severe sepsis in critically ill infected patients. Am J Resp Crit Care Med. 2005;171:461-8.
9. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN). Report, data summary for 2010, device associated module. Am J Infect Control. 2011;39:798-816.
10. Sinuff T, Muscedere J, Cook D, et al. Implementation of clinical practice guidelines for ventilator-associated pneumonia: a multicenter prospective study. Crit Care Med. 2013;41:15-23.
11. • Bouadma L, Wolff M, Lucet JC. Ventilator-associated pneumonia and its prevention. Curr Opin Infect Dis. 2012;25:395-404. Long-term experience with a VAP bundle.
12. Zilberberg MD, Shorr AF, Kollef MH. Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med. 2009;37:305-9.
13. Bouadma L, Deslandes E, Lolom I, et al. Long-term impact of a multifaceted prevention program on ventilator-associated pneumonia in a medical intensive care unit. Clin Infect Dis. 2010;51:1115-22.
14. Bouadma L, Mourvillier B, Deiler V, et al. Changes in knowledge, beliefs, and perceptions throughout a multifaceted behavorial program aim at preventing ventilator-associated pneumonia. Intensive Care Med. 2010;36:1341-7.
15. Bouadma L, Mourvillier B, Deiler V, et al. A multifaceted program to prevent ventilator-associated pneumonia: impact on compliance with preventive measures. Crit Care Med. 2010;38:789-96.
16. Morris AC, Hay AW, Swann DG, et al. Reducing ventilator-associated pneumonia in intensive care: impact of implementing a care bundle. Crit Care Med. 2011;39:2218-24.
17. • Melsen WG, Rovers MM, Koeman M, et al. Estimating the attributable mortality of ventilator-associated pneumonia from randomized prevention studies. Crit Care Med. 2011;39:2736-42. Large review of prevention measure studies.
18. • Klompas M. Ventilator-associated pneumonia: is zero possible? Clin Infect Dis. 2010;51:1123-6. Excellent review on critical aspects of the VAP bundle.
19. Klompas M. Is a ventilator-associated pneumonia rate of zero really possible? Curr Opin Infect Dis. 2012;25:176-82.
20. Klompas M, Magill S, Robicsek A, et al. Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med. 2012;40:3154-61.
21. Klompas M, Kleiman K, Khan Y, et al. CDC Prevention Epicenters Program: rapid and reproducible surveillance for ventilator-associated pneumonia. Clin Infect Dis. 2012;54:370-7.
22. Hayashi Y, Morisawa K, Klompas M, et al. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis. 2013;56:471-7.
23. Girou E, Stephan F, Novara A, et al. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med. 1998;157:1151-8.
24. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units; results of a multicenter prospective study. Crit Care Med. 1998;26:1793-800.
25. Moreno R, Vincent JL, Matos R, et al. The use of maximim SOFA score to quantify organ dysfunction/failure in intensive care. Results of a multicentre prospective study. Intensive Care Med. 1999;25:686-96.
26. Damas P, Ledoux D, Nys M, et al. Intensive care unit acquired infection and organ failures. Intensive Care Med. 2008;34:856-64.
27. Damas P, Layios N, Seidel L, et al. Severity of ICU-acquired pneumonia according to infectious microorganisms. Intensive Care Med. 2011;37:1128-35.
28. Depuydt PO, Vandijck DM, Bekaert MA, et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated pneumonia. Crit Care. 2008. doi: 10.1186/cc7119.
29. •• Bekaert M, Timsit JF, Vansteelandt S, et al. Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis. Am J Respir Crit Care Med. 2011;184:1133-9. New statistical method with new findings.
30. Muscedere JG, Day A, Heyland DK. Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia. Clin Infect Dis. 2010;51:S120-5.
31. Magret M, Amayar-Villar R, Garnacho J, et al. Ventilator-associated pneumonia in trauma patients is associated with lower mortality: results of EU-VAP study. J Trauma. 2010;69:849-54.
32. Josephson SA, Moheet AM, Gropper MA, et al. Ventilator-associated pneumonia in a neurologic intensive care unit does not lead to increased mortality. Neurocrit Care. 2010;12:155-8.
33. Grgurich PE, Hudcova J, Lei Y, et al. Diagnosis of ventilator associated pneumonia: controversies and working toward a gold standard. Curr Opin Infect Dis. 2013;26:140-50.